Page last updated: 2024-10-25

desipramine and Cyanosis

desipramine has been researched along with Cyanosis in 1 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Cyanosis: A bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tomii, T1
Honjo, O1
Matsumoto, T1
Tachibana, H1
Fujii, Y1
Ishino, K1
Ogasawara, Y1
Sano, S1

Other Studies

1 other study available for desipramine and Cyanosis

ArticleYear
Impact of chronic cyanosis and reoxygenation on the microheterogeneity of the myocardial blood flow: digital radiographic study in neonatal rats.
    General thoracic and cardiovascular surgery, 2011, Volume: 59, Issue:10

    Topics: Age Factors; Aging; Animals; Animals, Newborn; Chronic Disease; Coronary Circulation; Cyanosis; Desi

2011